Bacteriophages are powerful tools in genetic medicine. This book explores their use to create targeted gene delivery systems, vaccines, and immunotherapeutics, highlighting phage-based platforms as cost-effective, scalable alternatives to traditional viral vectors.
Read MoreNovel treatment uses bacterial virus already in the body to give new hope for combatting deadly genetic disorders.
An innovative method that uses modified versions of a bacterial virus effective at delivering treatments to human cells shows promise as a more inexpensive and efficient way to treat some deadly genetic diseases.
Read MoreInstead of filling a vaccine bank with many vaccines against different potential coronaviruses, some researchers are trying to come up with a single vaccine that will work against a variety of different coronaviruses.
Read MoreIf you don't like needles, you may be interested in the COVID-19 vaccine being developed at the University of Waterloo. It's being designed for administration as a nasal spray.
Read MoreTheraphage is committed to doing our part in trying to overcome the current COVID-19 pandemic.
Read MoreHeld at Catalyst137 in Kitchener, Ontario on February 27, Theraphage was one of ten finalists pitching for over $200k in investments. Learn more about the competition and watch our pitch!
Read More
